<DOC>
	<DOCNO>NCT00861458</DOCNO>
	<brief_summary>This study test two different formulation . The result use select formulation phase 3 .</brief_summary>
	<brief_title>Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets ( Wet Granulate , 3x250mg Oral Tablets ( Dry Granulate ) And 750mg Solution Under Fed State</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Healthy volunteer . Standard healthy volunteer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>